Page 38 - GPD-3-2

Gene & Protein in Disease β-cell regeneration and stem cell niche

responsive pancreatic islet cells from pancreatic stem cells. crucial for disorders like Type 1 diabetes (T1D) that cause
These advancements have revealed new signaling pathways islet cell loss. Additional techniques include inducing
7
and molecules involved in lineage commitment during natural β-cell proliferation, transforming non-β-cells into
pancreatic differentiation and maturation processes, β-like cells, and isolating islets from genetically altered
enhancing in vitro pancreatic maturation methods. animals. Recent technological developments and analytical
2
Regenerative treatments made possible by stem cell techniques for genome-wide research at the single-cell
biology hold revolutionary potential; yet, the regulatory level can help identify disease-specific cell subpopulations
networks that control the formation of complex tissues and relate them to genetic risk factors, allowing for
and organs are still poorly understood, limiting these personalized precision-based therapy. Enhanced resolution
therapies’ applications. Stem cell engineering addresses and specificity afforded by these technologies, combined
these complexities by exploring gene regulatory networks with the interdisciplinary convergence of engineering and
in individual stem cells and systemic relationships across biology, will enable the development of therapeutically
organs and tissues. Single-cell sequencing technology, exploitable niches. Decoding and understanding molecular
3
8
which analyzes cell heterogeneity at the single-cell level, mechanisms in cell signaling pathways, pancreatic cell
has advanced significantly due to advancements in cell regeneration, and the engineering of stem cell niches will
sorting and nucleic acid extraction. Recent findings in open new avenues for treating and regenerating pancreatic
stem cell research, such as pluripotent stem cells (PSCs) cells in the near future.
and tissue-specific stem cells, have been encouraging.
While the potential of stem cells in regenerative medicine 2. Cell signaling pathways and pancreatic
is well-discussed, the development of actual medicines β-cell regeneration
has been slow. The goal is to construct a biofunctional
artificial niche for multipotency, differentiation, and The loss or dysfunction of pancreatic insulin-producing
proliferation, allowing for more definitive experiments by cells leads to diabetes, a global health concern of
pharmaceutical specialists, biologists, and tissue engineers. paramount importance. It is essential to recognize the
The therapeutic potential of pancreatic islet cells derived inherent capacity of diabetic patients’ cells to proliferate
from pancreatic stem cells is being explored through gene- under both normal and pathological conditions, as this
editing techniques and cell transplantation into diabetic capacity is integral to restoring functional cell mass.
4
animal models. These cells have potential use in drug Recent advancements in understanding the mechanisms
testing and disease modeling research. Artemether and underlying the differentiation of various pancreatic cell
gamma-aminobutyric acid (GABA) can induce pancreatic lineages into insulin-producing cells have been facilitated
cells to adopt a β-cell-like phenotype, potentially promoting by developments in cell regeneration in vivo. Reactivation
the development of new β-cell-like cells for treating severe of the gene encoding the transcription factor neurogenin-3,
diabetes in rats. which regulates pancreatic endocrine cells, is a key
component of these pathways. The pancreas, composed
Understanding the signaling pathways linked to of the exocrine pancreas and endocrine islets, functions
G-protein-coupled receptor (GPCR) activation and in enzyme storage and insulin production. Islet cell loss
their interactions within cells is crucial for developing occurring in conditions such as T1D requires therapeutic
therapeutic methods to regulate insulin secretion and intervention due to the limited regeneration capacity
maintain cell mass. Apoptosis induced by diabetogenic of the cells. The most effective methods involve creating
stresses results in a reduction in functioning cells as and transplanting fresh cells from human PSCs, inducing
diabetes progresses. It is essential to prevent the loss of cell endogenous β-cell proliferation, transforming non-β-cells
molecular characteristics, as this loss results in decreased into β-like cells, and extracting islets from genetically
cell mass and impaired function. This review focuses on engineered animals (Figure 1). Pancreatic regeneration
the causes, consequences, and potential reversibility of cell emerges as a potential therapeutic method for the recovery
failure as a treatment approach for T2D. Dedifferentiated of cell loss.
5
cells have the ability to redifferentiate into mature,
functioning cells, indicating that dedifferentiation is not The ability of endocrine islets to regenerate is limited,
an irreversible process. Thus, therapeutic approaches especially in adults. Most hypoglycemic medications can
that prevent cell dedifferentiation and promote cell preserve cells by reducing oxidative stress and inflammation
6
regeneration hold promise for treating T2D. The pancreas caused by hyperglycemia, and by inhibiting cell death
comprises the exocrine pancreas, which stores digestive and dedifferentiation. Compounds such as glucagon-like
enzymes, and the endocrine islets, which produce the peptide-1 and GABA increase cell proliferation believed
essential metabolic hormone — insulin. Treatment is to be the primary source of regenerated cells in adult rats,

Volume 3 Issue 2 (2024) 2 doi: 10.36922/gpd.2996